Item 9 Labs's EBIT per Share for the
three
months ended in Jun. 2023 was $-0.03.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.22.
During the past 3 years, the average EBIT per Share Growth Rate was -24.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Item 9 Labs's EBIT per Share or its related term are showing as below:
INLB'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -150.1 Med: 16.35 Max: 51.9
Current: -24.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Item 9 Labs was 51.90% per year. The lowest was -150.10% per year. And the median was 16.35% per year.
INLB's 3-Year EBIT Growth Rate is ranked worse than 85.95% of 854
companies
in the Drug Manufacturers industry
Industry Median: 7.7
vs INLB: -24.50
Item 9 Labs's EBIT for the
three
months ended in Jun. 2023 was $-2.96 Mil.
Item 9 Labs EBIT per Share Historical Data
The historical data trend for Item 9 Labs's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Item 9 Labs (OTCPK:INLB) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Item 9 Labs EBIT per Share Related Terms
Thank you for viewing the detailed overview of Item 9 Labs's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INLB has been successfully added to your 